Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-23

FDA Approved: ALCAFTADINE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approved the Original Application for ALCAFTADINE by Aurohealth LLC, establishing a generic version of the antihistamine eye drop. The approval enables mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALCAFTADINE (ALCAFTADINE)

Snippet

ORIG AP for ALCAFTADINE (ALCAFTADINE)